Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 814 across all filing types
Latest filing 2024-03-15 Remuneration Information
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Report on the remuneration policy for the year 2024 and remuneration paid in the year 2023
Remuneration Information Classification · 100% confidence The document is explicitly titled "REPORT ON THE REMUNERATION POLICY for the year 2024 and Remuneration paid in the year 2023". It discusses compensation, executive pay, board remuneration, and links these topics to the company's ESG 'Social' plan and merit principles. This content directly aligns with the definition of a Remuneration Information document, which corresponds to the DEF 14A filing type in the provided schema, even though the document itself is a standalone report rather than a proxy statement. Specifically, the document details the remuneration policy and the actual remuneration paid, which is the core function of a DEF 14A (or equivalent remuneration report in non-US jurisdictions, which maps best to this category based on content). The length (236,555 chars) confirms it is the full report, not just an announcement (RPA/RNS).
2024-03-15 English
Relazione sulla politica in materia di remunerazione per l'esercizio 2024 e sui compensi corrisposti nell'esercizio 2023
Remuneration Information Classification · 99% confidence The document title is "RELAZIONE SULLA POLITICA IN MATERIA DI REMUNERAZIONE per l'esercizio 2024 e sui compensi corrisposti nell'esercizio 2023" (Report on Remuneration Policy for the year 2024 and on compensation paid in the year 2023). This explicitly indicates the document's focus is on executive and director compensation policies and past remuneration, which aligns directly with the definition of Remuneration Information (DEF 14A). The content discusses the 'Principi del Merito' (Principles of Merit), performance, compensation structure, and includes a section titled 'Parte seconda - Rappresentazione analitica dei' which details remuneration elements, confirming the subject matter. Although the document is long (over 250k characters), its core subject is remuneration, making DEF 14A the most specific and accurate classification, rather than the general 'DEF 14A' which is listed as Remuneration Information.
2024-03-15 Italian
Shareholders' Meeting April 24, 2024 - Reports and motions for resolutions
AGM Information Classification · 98% confidence The document is titled 'SHAREHOLDERS' MEETING DiaSorin S.p.A.' and contains 'EXPLANATORY REPORTS AND PROPOSED RESOLUTIONS ON THE ITEMS ON THE AGENDA'. It explicitly details proposals for the approval of Financial Statements (Item 1), Remuneration Policy (Item 2), and the Appointment of a statutory auditor (Item 3). These documents, which outline proposals and explanatory reports to be voted upon at a general meeting, are characteristic of materials prepared for a Shareholders' Meeting. Since it contains the explanatory reports and proposed resolutions for the meeting, it aligns best with the 'AGM Information' category, which covers presentations and materials shared during the Annual General Meeting (AGM). It is not the final voting results (DVA) nor the full Annual Report (10-K).
2024-03-15 Italian
Assemblea Ordinaria degli Azionisti 24 aprile 2024 – Relazioni Illustrative e proposte di delibera
AGM Information Classification · 98% confidence The document is titled "ASSEMBLEA DEGLI AZIONISTI DiaSorin S.p.A." (Shareholders' Meeting) and contains "RELAZIONI ILLUSTRATIVE E PROPOSTE DI DELIBERA SUGLI ARGOMENTI ALL'ORDINE DEL GIORNO" (Illustrative Reports and Proposals for Resolutions on the Agenda Items). The agenda items cover the approval of the 2023 Financial Statements (Point 1), the Remuneration Policy (Point 2), and the appointment of the statutory auditor (Point 3). This structure, detailing proposals to be voted on at a general meeting, strongly indicates materials prepared for the Annual General Meeting (AGM). While it discusses the Annual Financial Statements (Bilancio di esercizio al 31 dicembre 2023), the document itself is the explanatory report accompanying the meeting agenda, not the full 10-K or the standalone Audit Report. The presence of specific proposals for shareholder votes aligns perfectly with AGM materials.
2024-03-15 Italian
DiaSorin S.p.A. - Assemblea Ordinaria degli Azionisti del 24 aprile 2024 - Modulo di delega ex art. 135-undecies TUF
Proxy Solicitation & Information Statement Classification · 99% confidence The document is titled "MODULO DI CONFERIMENTO DELLA DELEGA AL RAPPRESENTANTE DESIGNATO AI SENSI DELL'ART. 135-UNDECIES DEL D. LGS. 58/1998 ('TUF')" and contains instructions and a form for shareholders to delegate their voting rights for an upcoming Ordinary Shareholders' Meeting (Assemblea Ordinaria) of DIASORIN S.p.A. on April 24, 2024. This document is specifically designed to solicit shareholder votes and provide instructions for voting at a general meeting, which aligns directly with the definition of Proxy Solicitation & Information Statement (PSI). While it deals with remuneration reports (2.1, 2.2) and the annual report (1.1), the primary function of this document is the solicitation of proxy votes, not the distribution of the reports themselves. It is a mechanism for voting at the AGM, making PSI the most accurate classification.
2024-03-15 Italian
Shareholders' Meeting April 24, 2024 - Proxy forms ex art. 135-undecies TUF
Proxy Solicitation & Information Statement Classification · 100% confidence The document is explicitly titled 'PROXY FORM TO THE DESIGNATED REPRESENTATIVE' and details the process for shareholders to grant voting proxies for an upcoming 'Ordinary General Meeting' (AGM) scheduled for April 24, 2024. It outlines voting instructions, required personal details for proxy signing, and references specific Italian legislative decrees related to shareholder meetings and proxy voting (Art. 135-undecies of Legislative Decree 58/1998). This content is characteristic of materials used to solicit shareholder votes ahead of a general meeting, which falls under the definition of Proxy Solicitation & Information Statement (PSI). Although it relates to an AGM, the document's function is soliciting the proxy vote, not presenting the AGM materials themselves (AGM-R) or the results (DVA).
2024-03-15 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.